ALTRAPHARMA Invest ApS: Financial statements 2013
CVR: 34483884
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 1,373,710 and a net result of DKK 145,072. Equity in the 2013 report amounted to DKK 649,505. The solvency ratio was 56.8%.
- Gross Profit
- DKK 1,373,710
- Profit/Loss
- DKK 145,072
- Equity
- DKK 649,505
- Total Assets
- DKK 1,144,164
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ALTRAPHARMA Invest ApS has published its interim report for the period April 18, 2012 – December 31, 2012.
As of January 1, 2013, AP STATSAUTORISEREDE REVISORER P/S has been appointed auditor of ALTRAPHARMA Invest ApS.
About ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.